CATALYST FINANCIAL PARTNERS LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1927537 BOSTON, MA

Position in BMY

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$512,472

-$83,717 QoQ

Shares Held

8,894

-9.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,525

of 2,514 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $23,806,391 across 9 Drug Manufacturers - General names. BMY ranks #8 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,449	$7,735,124
2	JNJ	Johnson & Johnson	24,867	$6,315,471
3	ABBV	AbbVie Inc.	15,393	$3,873,494
4	MRK	Merck & Co., Inc.	20,205	$2,596,342
5	AMGN	Amgen Inc	3,386	$1,226,138
6	GILD	Gilead Sciences, Inc.	5,716	$722,159
7	PFE	Pfizer Inc	25,150	$605,612
8	BMY	Bristol Myers Squibb Co This page	8,894	$512,472

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$512,472	8,894	-9.5%	Shares	Sole	2026-07-30
2026-03-31	$596,189	9,830	+5.8%	Shares	Sole	2026-05-12
2025-12-31	$501,210	9,292	+27.3%	Shares	Sole	2026-02-04
2025-09-30	$329,230	7,300	-8.2%	Shares	Sole	2025-11-12
2025-06-30	$368,144	7,953	-4.8%	Shares	Sole	2025-08-14
2025-03-31	$509,327	8,351	+8.3%	Shares	Sole	2025-05-02
2024-12-31	$436,021	7,709	+24.0%	Shares	Sole	2025-01-30
2024-09-30	$321,771	6,219	+25.4%	Shares	Sole	2024-10-28
2024-06-30	$205,988	4,960	-24.6%	Shares	Sole	2024-07-25
2024-03-31	$356,887	6,581	+10.7%	Shares	Sole	2024-04-23
2023-12-31	$304,986	5,944	-21.5%	Shares	Sole	2024-02-07
2023-09-30	$439,478	7,572	+22.3%	Shares	Sole	2023-10-26
2023-06-30	$395,850	6,190	+3.1%	Shares	Sole	2023-08-02
2023-03-31	$415,929	6,001	+2.5%	Shares	Sole	2023-04-11
2022-12-31	$421,339	5,856	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.